Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
申请人:Bristol-Myers Squibb Company
公开号:US06255496B1
公开(公告)日:2001-07-03
Selective inhibitors of the cPLA2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula